Neuromuscular monitoring should be required when neuromuscular blocking drugs are used: Is it time to change the Canadian guidelines?
Department of Anesthesiology & Pain Medicine, University of Alberta, Edmonton, AB, Canada. rj.hudson@ualberta.ca.
Robert J
RJ
Hudson
D002170:Canada; D006801:Humans; D019148:Neuromuscular Blockade / Q000379:methods*; D009466:Neuromuscular Blocking Agents; D061886:Neuromuscular Monitoring / Q000379:methods*; D017410:Practice Guidelines as Topic
D009466:Neuromuscular Blocking Agents